Want to see AU:ADO full AI Analyst Report?
ADO Stock Chart & Stats
AU$0.02
>-AU$0.01(>-0.01%)
At close: 4:00 PM EDT
AU$0.02
>-AU$0.01(>-0.01%)
Day’s Range― - ―
52-Week RangeAU$0.01 - AU$0.05
Previous CloseN/A
Volume2.78M
Average Volume (3M)2.38M
Market Cap
AU$52.24M
Enterprise ValueAU$71.97M
Total Cash (Recent Filing)AU$11.20M
Total Debt (Recent Filing)AU$2.15M
Price to Earnings (P/E)―
Beta1.80
Next Earnings
Mar 03, 2027EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding3,265,153,800
10 Day Avg. Volume1,389,635
30 Day Avg. Volume2,381,649
Financial Highlights & Ratios
PEG Ratio0.55
Price to Book (P/B)6.74
Price to Sales (P/S)170.19
P/FCF Ratio-22.20
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)AU$2.80M
Bulls Say, Bears Say
Bulls Say
Moderate LeverageModerate leverage gives AnteoTech greater financial flexibility than a heavily debt-funded structure. Lower debt exposure can reduce interest and refinancing pressure, helping preserve capacity to support product development and commercialisation while the company works toward stronger operating performance.
Improving Cash OutflowsThe reduction in operating and free cash outflows indicates some progress in cash discipline, even though the company remains cash-flow negative. If sustained, this improvement could extend funding runway and reduce the pace at which external capital is required for ongoing operations.
Some Historical Loss NarrowingPeriods of narrower losses suggest that AnteoTech has demonstrated some ability to reduce the scale of earnings deficits. Although this has not yet produced break-even results, continued improvement would strengthen operating leverage and make future commercial growth more valuable to shareholders.
Bears Say
Sharp Revenue DeclineA sharp decline in already small and volatile revenue weakens confidence in the current commercial traction of AnteoTech’s diagnostics and energy-storage technologies. Sustained top-line instability can limit operating leverage, constrain investment capacity, and make progress toward profitability more difficult.
Persistent Operating LossesPersistent, substantial operating losses show that the business has not yet established a durable path to break-even. Continued losses can consume available resources, reduce the benefits of revenue growth, and require management to prioritise funding needs before expanding investment in commercial opportunities.
Ongoing Cash BurnNegative operating and free cash flow across every reported period means AnteoTech continues to rely on funding rather than internally generated cash. This weakens financial resilience, creates ongoing capital requirements, and may restrict the company’s ability to sustain development and commercialisation activities independently.
AnteoTech Ltd News
ADO FAQ
What was AnteoTech Ltd’s price range in the past 12 months?
AnteoTech Ltd lowest share price was AU$0.01 and its highest was AU$0.05 in the past 12 months.
What is AnteoTech Ltd’s market cap?
AnteoTech Ltd’s market cap is AU$52.24M.
When is AnteoTech Ltd’s upcoming earnings report date?
AnteoTech Ltd’s upcoming earnings report date is Mar 03, 2027 which is in 124 days.
How were AnteoTech Ltd’s earnings last quarter?
AnteoTech Ltd released its earnings results on Sep 27, 2026. The company reported -AU$0.001 earnings per share for the quarter.
Is AnteoTech Ltd overvalued?
According to Wall Street analysts AnteoTech Ltd’s price is currently Overvalued.
Does AnteoTech Ltd pay dividends?
AnteoTech Ltd does not currently pay dividends.
What is AnteoTech Ltd’s EPS estimate?
AnteoTech Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does AnteoTech Ltd have?
AnteoTech Ltd has 3,265,153,800 shares outstanding.
What happened to AnteoTech Ltd’s price movement after its last earnings report?
AnteoTech Ltd reported an EPS of -AU$0.001 in its last earnings report. Following the earnings report the stock price went down -7.692%.
Which hedge fund is a major shareholder of AnteoTech Ltd?
Currently, no hedge funds are holding shares in AU:ADO
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
AnteoTech Ltd Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
AU:ADO Sentiment 97%
Sector Average 68%
Sector Average 68%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-26.31%
12-Months-Change
Fundamentals
Return on Equity
-77.75%
Trailing 12-Months
Asset Growth
131.91%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
AnteoTech Ltd
AnteoTech Limited develops, manufactures, commercializes, and distributes products for clean energy technology and life science markets primarily in Australia, Asia, Europe, and North America. The company’s products include AnteoBind, a metal-ion complex-based activation technology that offers an alternative to conventionally used chemistries for the life sciences industry; AnteoBind NXT solution for the development of diagnostic tests; AnteoBind Micro and Micro Kit, a micro-particle-based assay development and bioseparation; AnteoBind Sub-Micron, Particle-based assay development, and bioseparation; AnteoBind Biosensor, a planar solid phase assay development; Activation Kit Multiplex Microspheres, an immunoassay development; and Nano Kit, a nanoparticle-based lateral flow assay development and bioseparation. It also provides AnteoX, an additive that reinforces battery binders that enhance performance of silicon containing anodes; and Ultranode, an ultra-high silicon anode design to offer high performance for lithium-ion batteries. In addition, the company offers contract services. The company was formerly known as Anteo Diagnostics Limited and changed its name to AnteoTech Limited in November 2019. AnteoTech Limited is headquartered in Eight Mile Plains, Australia.
Technical Analysis
Starpharma Holdings Limited
―
Telix Pharmaceuticals
―
Clarity Pharmaceuticals Ltd.
―
Proteomics International Laboratories Ltd.
―
Radiopharm Theranostics Limited
―